Began Research on Sickle Cell Disease at Harbor UCLA

Received funding from NIH for continued research in Sickle Cell Disease

Received FDA grant and Founded Emmaus Life Sciences

Phase I Clinical trials

Phase II Clinical Trials

Phase III Clinical Trials

FDA approval for first ever treatment of Sickle Cell Disease in pediatric patients and first treatment for Sickle Cell Disease in 20 years

Availability of Endari? (L-glutamine oral powder) for Sickle Cell Disease in the United States